My Rewards International Limited (MRI.AX) Stock Competitors & Peer Comparison
See (MRI.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Application Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MRI.AX | A$0.01 | N/A | 8.2M | -2.52 | -A$0.00 | N/A |
| XRO.AX | A$73.40 | -1.26% | 12.7B | 88.15 | A$0.83 | N/A |
| WTC.AX | A$34.00 | -1.82% | 11.4B | 30.33 | A$1.12 | +0.63% |
| TNE.AX | A$30.80 | +0.79% | 10.1B | 72.76 | A$0.42 | +1.23% |
| ALU.AX | A$68.33 | +0.07% | 9B | 84.36 | A$0.81 | +0.86% |
| 360.AX | A$25.68 | -0.93% | 6.2B | 24.14 | A$1.06 | N/A |
| PXA.AX | A$8.10 | -0.37% | 1.4B | -63.46 | -A$0.13 | N/A |
| IRE.AX | A$6.31 | -1.10% | 1.2B | 20.42 | A$0.31 | +3.80% |
| RUL.AX | A$4.99 | +0.00% | 1.1B | 166.33 | A$0.03 | N/A |
| BVS.AX | A$2.36 | +15.12% | 1.1B | 27.11 | A$0.09 | +6.33% |
Stock Comparison
MRI.AX vs XRO.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, XRO.AX has a market cap of 12.7B. Regarding current trading prices, MRI.AX is priced at A$0.01, while XRO.AX trades at A$73.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas XRO.AX's P/E ratio is 88.15. In terms of profitability, MRI.AX's ROE is +0.47%, compared to XRO.AX's ROE of +0.04%. Regarding short-term risk, MRI.AX is less volatile compared to XRO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check XRO.AX's competition here
MRI.AX vs WTC.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, WTC.AX has a market cap of 11.4B. Regarding current trading prices, MRI.AX is priced at A$0.01, while WTC.AX trades at A$34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas WTC.AX's P/E ratio is 30.33. In terms of profitability, MRI.AX's ROE is +0.47%, compared to WTC.AX's ROE of +0.09%. Regarding short-term risk, MRI.AX is less volatile compared to WTC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check WTC.AX's competition here
MRI.AX vs TNE.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, TNE.AX has a market cap of 10.1B. Regarding current trading prices, MRI.AX is priced at A$0.01, while TNE.AX trades at A$30.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas TNE.AX's P/E ratio is 72.76. In terms of profitability, MRI.AX's ROE is +0.47%, compared to TNE.AX's ROE of +0.32%. Regarding short-term risk, MRI.AX is less volatile compared to TNE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check TNE.AX's competition here
MRI.AX vs ALU.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ALU.AX has a market cap of 9B. Regarding current trading prices, MRI.AX is priced at A$0.01, while ALU.AX trades at A$68.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ALU.AX's P/E ratio is 84.36. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ALU.AX's ROE of +0.23%. Regarding short-term risk, MRI.AX is less volatile compared to ALU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ALU.AX's competition here
MRI.AX vs 360.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, 360.AX has a market cap of 6.2B. Regarding current trading prices, MRI.AX is priced at A$0.01, while 360.AX trades at A$25.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas 360.AX's P/E ratio is 24.14. In terms of profitability, MRI.AX's ROE is +0.47%, compared to 360.AX's ROE of +0.32%. Regarding short-term risk, MRI.AX is less volatile compared to 360.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check 360.AX's competition here
MRI.AX vs PXA.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, PXA.AX has a market cap of 1.4B. Regarding current trading prices, MRI.AX is priced at A$0.01, while PXA.AX trades at A$8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas PXA.AX's P/E ratio is -63.46. In terms of profitability, MRI.AX's ROE is +0.47%, compared to PXA.AX's ROE of -0.05%. Regarding short-term risk, MRI.AX is less volatile compared to PXA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check PXA.AX's competition here
MRI.AX vs IRE.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, IRE.AX has a market cap of 1.2B. Regarding current trading prices, MRI.AX is priced at A$0.01, while IRE.AX trades at A$6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas IRE.AX's P/E ratio is 20.42. In terms of profitability, MRI.AX's ROE is +0.47%, compared to IRE.AX's ROE of +0.20%. Regarding short-term risk, MRI.AX is less volatile compared to IRE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check IRE.AX's competition here
MRI.AX vs RUL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, RUL.AX has a market cap of 1.1B. Regarding current trading prices, MRI.AX is priced at A$0.01, while RUL.AX trades at A$4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas RUL.AX's P/E ratio is 166.33. In terms of profitability, MRI.AX's ROE is +0.47%, compared to RUL.AX's ROE of +0.64%. Regarding short-term risk, MRI.AX is less volatile compared to RUL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check RUL.AX's competition here
MRI.AX vs BVS.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, BVS.AX has a market cap of 1.1B. Regarding current trading prices, MRI.AX is priced at A$0.01, while BVS.AX trades at A$2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas BVS.AX's P/E ratio is 27.11. In terms of profitability, MRI.AX's ROE is +0.47%, compared to BVS.AX's ROE of +0.43%. Regarding short-term risk, MRI.AX is less volatile compared to BVS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check BVS.AX's competition here
MRI.AX vs SDR.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SDR.AX has a market cap of 1B. Regarding current trading prices, MRI.AX is priced at A$0.01, while SDR.AX trades at A$3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SDR.AX's P/E ratio is -69.06. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SDR.AX's ROE of -0.26%. Regarding short-term risk, MRI.AX is less volatile compared to SDR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check SDR.AX's competition here
MRI.AX vs HSN.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, HSN.AX has a market cap of 856.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while HSN.AX trades at A$4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas HSN.AX's P/E ratio is 28.04. In terms of profitability, MRI.AX's ROE is +0.47%, compared to HSN.AX's ROE of +0.17%. Regarding short-term risk, MRI.AX is less volatile compared to HSN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check HSN.AX's competition here
MRI.AX vs FCL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, FCL.AX has a market cap of 703.9M. Regarding current trading prices, MRI.AX is priced at A$0.01, while FCL.AX trades at A$2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas FCL.AX's P/E ratio is 69.46. In terms of profitability, MRI.AX's ROE is +0.47%, compared to FCL.AX's ROE of -0.00%. Regarding short-term risk, MRI.AX is less volatile compared to FCL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check FCL.AX's competition here
MRI.AX vs OCL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, OCL.AX has a market cap of 665.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while OCL.AX trades at A$6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas OCL.AX's P/E ratio is 18.66. In terms of profitability, MRI.AX's ROE is +0.47%, compared to OCL.AX's ROE of +0.26%. Regarding short-term risk, MRI.AX is less volatile compared to OCL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check OCL.AX's competition here
MRI.AX vs C79.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, C79.AX has a market cap of 659.3M. Regarding current trading prices, MRI.AX is priced at A$0.01, while C79.AX trades at A$5.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas C79.AX's P/E ratio is -132.74. In terms of profitability, MRI.AX's ROE is +0.47%, compared to C79.AX's ROE of -0.02%. Regarding short-term risk, MRI.AX is less volatile compared to C79.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check C79.AX's competition here
MRI.AX vs IFM.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, IFM.AX has a market cap of 640.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while IFM.AX trades at A$1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas IFM.AX's P/E ratio is 42.38. In terms of profitability, MRI.AX's ROE is +0.47%, compared to IFM.AX's ROE of +0.12%. Regarding short-term risk, MRI.AX is less volatile compared to IFM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check IFM.AX's competition here
MRI.AX vs NTO.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, NTO.AX has a market cap of 559.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while NTO.AX trades at A$2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas NTO.AX's P/E ratio is -9.95. In terms of profitability, MRI.AX's ROE is +0.47%, compared to NTO.AX's ROE of -0.37%. Regarding short-term risk, MRI.AX is less volatile compared to NTO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check NTO.AX's competition here
MRI.AX vs VGL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, VGL.AX has a market cap of 490.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while VGL.AX trades at A$2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas VGL.AX's P/E ratio is 117.82. In terms of profitability, MRI.AX's ROE is +0.47%, compared to VGL.AX's ROE of +0.01%. Regarding short-term risk, MRI.AX is less volatile compared to VGL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check VGL.AX's competition here
MRI.AX vs ELO.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ELO.AX has a market cap of 483.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while ELO.AX trades at A$4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ELO.AX's P/E ratio is -5.68. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ELO.AX's ROE of -0.59%. Regarding short-term risk, MRI.AX is less volatile compared to ELO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ELO.AX's competition here
MRI.AX vs NXL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, NXL.AX has a market cap of 437M. Regarding current trading prices, MRI.AX is priced at A$0.01, while NXL.AX trades at A$1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas NXL.AX's P/E ratio is -796.30. In terms of profitability, MRI.AX's ROE is +0.47%, compared to NXL.AX's ROE of +0.04%. Regarding short-term risk, MRI.AX is less volatile compared to NXL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check NXL.AX's competition here
MRI.AX vs DSE.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, DSE.AX has a market cap of 418.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while DSE.AX trades at A$5.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas DSE.AX's P/E ratio is 588.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to DSE.AX's ROE of +0.03%. Regarding short-term risk, MRI.AX is less volatile compared to DSE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check DSE.AX's competition here
MRI.AX vs EOL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, EOL.AX has a market cap of 385.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while EOL.AX trades at A$12.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas EOL.AX's P/E ratio is 54.25. In terms of profitability, MRI.AX's ROE is +0.47%, compared to EOL.AX's ROE of +0.11%. Regarding short-term risk, MRI.AX is less volatile compared to EOL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check EOL.AX's competition here
MRI.AX vs SPZ.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SPZ.AX has a market cap of 325.9M. Regarding current trading prices, MRI.AX is priced at A$0.01, while SPZ.AX trades at A$0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SPZ.AX's P/E ratio is 32.71. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SPZ.AX's ROE of +0.06%. Regarding short-term risk, MRI.AX is less volatile compared to SPZ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check SPZ.AX's competition here
MRI.AX vs AND.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, AND.AX has a market cap of 235M. Regarding current trading prices, MRI.AX is priced at A$0.01, while AND.AX trades at A$2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas AND.AX's P/E ratio is -249.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to AND.AX's ROE of -0.02%. Regarding short-term risk, MRI.AX is less volatile compared to AND.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check AND.AX's competition here
MRI.AX vs SYM.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SYM.AX has a market cap of 226.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while SYM.AX trades at A$2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SYM.AX's P/E ratio is 131.50. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SYM.AX's ROE of +0.01%. Regarding short-term risk, MRI.AX is less volatile compared to SYM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check SYM.AX's competition here
MRI.AX vs BET.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, BET.AX has a market cap of 201.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while BET.AX trades at A$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas BET.AX's P/E ratio is -8.64. In terms of profitability, MRI.AX's ROE is +0.47%, compared to BET.AX's ROE of -0.13%. Regarding short-term risk, MRI.AX is less volatile compared to BET.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check BET.AX's competition here
MRI.AX vs RDY.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, RDY.AX has a market cap of 197.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while RDY.AX trades at A$1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas RDY.AX's P/E ratio is -1.50. In terms of profitability, MRI.AX's ROE is +0.47%, compared to RDY.AX's ROE of +0.01%. Regarding short-term risk, MRI.AX is less volatile compared to RDY.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check RDY.AX's competition here
MRI.AX vs BTH.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, BTH.AX has a market cap of 176.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while BTH.AX trades at A$0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas BTH.AX's P/E ratio is -2.39. In terms of profitability, MRI.AX's ROE is +0.47%, compared to BTH.AX's ROE of -0.06%. Regarding short-term risk, MRI.AX is less volatile compared to BTH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check BTH.AX's competition here
MRI.AX vs EVS.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, EVS.AX has a market cap of 130.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while EVS.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas EVS.AX's P/E ratio is -2.97. In terms of profitability, MRI.AX's ROE is +0.47%, compared to EVS.AX's ROE of -0.32%. Regarding short-term risk, MRI.AX and EVS.AX have similar daily volatility (0.00).Check EVS.AX's competition here
MRI.AX vs LME.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, LME.AX has a market cap of 116.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while LME.AX trades at A$0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas LME.AX's P/E ratio is -6.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to LME.AX's ROE of -1.04%. Regarding short-term risk, MRI.AX is less volatile compared to LME.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check LME.AX's competition here
MRI.AX vs MSL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, MSL.AX has a market cap of 108.9M. Regarding current trading prices, MRI.AX is priced at A$0.01, while MSL.AX trades at A$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas MSL.AX's P/E ratio is -49.17. In terms of profitability, MRI.AX's ROE is +0.47%, compared to MSL.AX's ROE of +0.04%. Regarding short-term risk, MRI.AX and MSL.AX have similar daily volatility (0.00).Check MSL.AX's competition here
MRI.AX vs YOJ.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, YOJ.AX has a market cap of 108.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while YOJ.AX trades at A$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas YOJ.AX's P/E ratio is -19.92. In terms of profitability, MRI.AX's ROE is +0.47%, compared to YOJ.AX's ROE of -1.05%. Regarding short-term risk, MRI.AX and YOJ.AX have similar daily volatility (0.00).Check YOJ.AX's competition here
MRI.AX vs HPG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, HPG.AX has a market cap of 99M. Regarding current trading prices, MRI.AX is priced at A$0.01, while HPG.AX trades at A$0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas HPG.AX's P/E ratio is 18.79. In terms of profitability, MRI.AX's ROE is +0.47%, compared to HPG.AX's ROE of +0.11%. Regarding short-term risk, MRI.AX is less volatile compared to HPG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check HPG.AX's competition here
MRI.AX vs BB1.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, BB1.AX has a market cap of 97.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while BB1.AX trades at A$0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas BB1.AX's P/E ratio is -10.58. In terms of profitability, MRI.AX's ROE is +0.47%, compared to BB1.AX's ROE of N/A. Regarding short-term risk, MRI.AX is less volatile compared to BB1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check BB1.AX's competition here
MRI.AX vs PTG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, PTG.AX has a market cap of 90.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while PTG.AX trades at A$0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas PTG.AX's P/E ratio is -29.75. In terms of profitability, MRI.AX's ROE is +0.47%, compared to PTG.AX's ROE of -0.07%. Regarding short-term risk, MRI.AX and PTG.AX have similar daily volatility (0.00).Check PTG.AX's competition here
MRI.AX vs IHR.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, IHR.AX has a market cap of 81.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while IHR.AX trades at A$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas IHR.AX's P/E ratio is -11.75. In terms of profitability, MRI.AX's ROE is +0.47%, compared to IHR.AX's ROE of -1.39%. Regarding short-term risk, MRI.AX is less volatile compared to IHR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check IHR.AX's competition here
MRI.AX vs VNL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, VNL.AX has a market cap of 78.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while VNL.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas VNL.AX's P/E ratio is -5.30. In terms of profitability, MRI.AX's ROE is +0.47%, compared to VNL.AX's ROE of -0.68%. Regarding short-term risk, MRI.AX and VNL.AX have similar daily volatility (0.00).Check VNL.AX's competition here
MRI.AX vs WSP.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, WSP.AX has a market cap of 76.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while WSP.AX trades at A$0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas WSP.AX's P/E ratio is -5.50. In terms of profitability, MRI.AX's ROE is +0.47%, compared to WSP.AX's ROE of -0.65%. Regarding short-term risk, MRI.AX is less volatile compared to WSP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check WSP.AX's competition here
MRI.AX vs ESK.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ESK.AX has a market cap of 75M. Regarding current trading prices, MRI.AX is priced at A$0.01, while ESK.AX trades at A$0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ESK.AX's P/E ratio is -11.37. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ESK.AX's ROE of -0.09%. Regarding short-term risk, MRI.AX is less volatile compared to ESK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ESK.AX's competition here
MRI.AX vs SKK.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SKK.AX has a market cap of 64.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while SKK.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SKK.AX's P/E ratio is N/A. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SKK.AX's ROE of -0.09%. Regarding short-term risk, MRI.AX is less volatile compared to SKK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check SKK.AX's competition here
MRI.AX vs IOD.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, IOD.AX has a market cap of 63.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while IOD.AX trades at A$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas IOD.AX's P/E ratio is -24.27. In terms of profitability, MRI.AX's ROE is +0.47%, compared to IOD.AX's ROE of +4.30%. Regarding short-term risk, MRI.AX is less volatile compared to IOD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check IOD.AX's competition here
MRI.AX vs DTC.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, DTC.AX has a market cap of 61.3M. Regarding current trading prices, MRI.AX is priced at A$0.01, while DTC.AX trades at A$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas DTC.AX's P/E ratio is -1.19. In terms of profitability, MRI.AX's ROE is +0.47%, compared to DTC.AX's ROE of -0.77%. Regarding short-term risk, MRI.AX is less volatile compared to DTC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check DTC.AX's competition here
MRI.AX vs UBN.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, UBN.AX has a market cap of 51.3M. Regarding current trading prices, MRI.AX is priced at A$0.01, while UBN.AX trades at A$0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas UBN.AX's P/E ratio is -20.90. In terms of profitability, MRI.AX's ROE is +0.47%, compared to UBN.AX's ROE of -0.17%. Regarding short-term risk, MRI.AX is less volatile compared to UBN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check UBN.AX's competition here
MRI.AX vs ROC.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ROC.AX has a market cap of 50.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while ROC.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ROC.AX's P/E ratio is -6.25. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ROC.AX's ROE of -8.70%. Regarding short-term risk, MRI.AX is less volatile compared to ROC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ROC.AX's competition here
MRI.AX vs IRI.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, IRI.AX has a market cap of 48.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while IRI.AX trades at A$0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas IRI.AX's P/E ratio is -0.33. In terms of profitability, MRI.AX's ROE is +0.47%, compared to IRI.AX's ROE of +0.07%. Regarding short-term risk, MRI.AX is less volatile compared to IRI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check IRI.AX's competition here
MRI.AX vs RKN.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, RKN.AX has a market cap of 48.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while RKN.AX trades at A$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas RKN.AX's P/E ratio is 13.20. In terms of profitability, MRI.AX's ROE is +0.47%, compared to RKN.AX's ROE of +0.29%. Regarding short-term risk, MRI.AX is less volatile compared to RKN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check RKN.AX's competition here
MRI.AX vs NVU.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, NVU.AX has a market cap of 47.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while NVU.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas NVU.AX's P/E ratio is -4.30. In terms of profitability, MRI.AX's ROE is +0.47%, compared to NVU.AX's ROE of -0.76%. Regarding short-term risk, MRI.AX is less volatile compared to NVU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check NVU.AX's competition here
MRI.AX vs CCG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, CCG.AX has a market cap of 46M. Regarding current trading prices, MRI.AX is priced at A$0.01, while CCG.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas CCG.AX's P/E ratio is 64.62. In terms of profitability, MRI.AX's ROE is +0.47%, compared to CCG.AX's ROE of +0.02%. Regarding short-term risk, MRI.AX is less volatile compared to CCG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check CCG.AX's competition here
MRI.AX vs K2F.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, K2F.AX has a market cap of 37.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while K2F.AX trades at A$0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas K2F.AX's P/E ratio is -6.23. In terms of profitability, MRI.AX's ROE is +0.47%, compared to K2F.AX's ROE of -0.46%. Regarding short-term risk, MRI.AX and K2F.AX have similar daily volatility (0.00).Check K2F.AX's competition here
MRI.AX vs VR1.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, VR1.AX has a market cap of 37.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while VR1.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas VR1.AX's P/E ratio is -4.55. In terms of profitability, MRI.AX's ROE is +0.47%, compared to VR1.AX's ROE of -0.60%. Regarding short-term risk, MRI.AX is less volatile compared to VR1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check VR1.AX's competition here
MRI.AX vs ADA.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ADA.AX has a market cap of 36.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while ADA.AX trades at A$0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ADA.AX's P/E ratio is -5.28. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ADA.AX's ROE of -0.41%. Regarding short-term risk, MRI.AX is less volatile compared to ADA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ADA.AX's competition here
MRI.AX vs DUB.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, DUB.AX has a market cap of 29.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while DUB.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas DUB.AX's P/E ratio is -1.06. In terms of profitability, MRI.AX's ROE is +0.47%, compared to DUB.AX's ROE of -2.03%. Regarding short-term risk, MRI.AX is less volatile compared to DUB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check DUB.AX's competition here
MRI.AX vs AMX.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, AMX.AX has a market cap of 27.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while AMX.AX trades at A$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas AMX.AX's P/E ratio is -5.91. In terms of profitability, MRI.AX's ROE is +0.47%, compared to AMX.AX's ROE of -0.27%. Regarding short-term risk, MRI.AX is less volatile compared to AMX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check AMX.AX's competition here
MRI.AX vs JAN.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, JAN.AX has a market cap of 26.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while JAN.AX trades at A$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas JAN.AX's P/E ratio is -4.49. In terms of profitability, MRI.AX's ROE is +0.47%, compared to JAN.AX's ROE of -0.55%. Regarding short-term risk, MRI.AX is less volatile compared to JAN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check JAN.AX's competition here
MRI.AX vs VIG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, VIG.AX has a market cap of 25.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while VIG.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas VIG.AX's P/E ratio is -341.67. In terms of profitability, MRI.AX's ROE is +0.47%, compared to VIG.AX's ROE of -0.03%. Regarding short-term risk, MRI.AX is less volatile compared to VIG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check VIG.AX's competition here
MRI.AX vs JXT.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, JXT.AX has a market cap of 25.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while JXT.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas JXT.AX's P/E ratio is -2.45. In terms of profitability, MRI.AX's ROE is +0.47%, compared to JXT.AX's ROE of -5.81%. Regarding short-term risk, MRI.AX is less volatile compared to JXT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check JXT.AX's competition here
MRI.AX vs AHI.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, AHI.AX has a market cap of 24.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while AHI.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas AHI.AX's P/E ratio is -4.44. In terms of profitability, MRI.AX's ROE is +0.47%, compared to AHI.AX's ROE of -2.19%. Regarding short-term risk, MRI.AX is less volatile compared to AHI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check AHI.AX's competition here
MRI.AX vs 3DP.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, 3DP.AX has a market cap of 23.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while 3DP.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas 3DP.AX's P/E ratio is -0.11. In terms of profitability, MRI.AX's ROE is +0.47%, compared to 3DP.AX's ROE of +1.90%. Regarding short-term risk, MRI.AX is less volatile compared to 3DP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check 3DP.AX's competition here
MRI.AX vs SNS.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SNS.AX has a market cap of 21.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while SNS.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SNS.AX's P/E ratio is 10.74. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SNS.AX's ROE of +0.23%. Regarding short-term risk, MRI.AX is less volatile compared to SNS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check SNS.AX's competition here
MRI.AX vs LVH.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, LVH.AX has a market cap of 19.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while LVH.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas LVH.AX's P/E ratio is -1.43. In terms of profitability, MRI.AX's ROE is +0.47%, compared to LVH.AX's ROE of -1.55%. Regarding short-term risk, MRI.AX and LVH.AX have similar daily volatility (0.00).Check LVH.AX's competition here
MRI.AX vs ATV.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ATV.AX has a market cap of 18.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while ATV.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ATV.AX's P/E ratio is -0.70. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ATV.AX's ROE of -1.27%. Regarding short-term risk, MRI.AX is less volatile compared to ATV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ATV.AX's competition here
MRI.AX vs ICE.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ICE.AX has a market cap of 18.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while ICE.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ICE.AX's P/E ratio is -4.40. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ICE.AX's ROE of -1.53%. Regarding short-term risk, MRI.AX is less volatile compared to ICE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ICE.AX's competition here
MRI.AX vs UNT.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, UNT.AX has a market cap of 18.3M. Regarding current trading prices, MRI.AX is priced at A$0.01, while UNT.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas UNT.AX's P/E ratio is -5.11. In terms of profitability, MRI.AX's ROE is +0.47%, compared to UNT.AX's ROE of -0.44%. Regarding short-term risk, MRI.AX and UNT.AX have similar daily volatility (0.00).Check UNT.AX's competition here
MRI.AX vs CF1.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, CF1.AX has a market cap of 18.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while CF1.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas CF1.AX's P/E ratio is -6.67. In terms of profitability, MRI.AX's ROE is +0.47%, compared to CF1.AX's ROE of -0.62%. Regarding short-term risk, MRI.AX and CF1.AX have similar daily volatility (0.00).Check CF1.AX's competition here
MRI.AX vs SCL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SCL.AX has a market cap of 18M. Regarding current trading prices, MRI.AX is priced at A$0.01, while SCL.AX trades at A$0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SCL.AX's P/E ratio is -16.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SCL.AX's ROE of -1.50%. Regarding short-term risk, MRI.AX and SCL.AX have similar daily volatility (0.00).Check SCL.AX's competition here
MRI.AX vs CXZ.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, CXZ.AX has a market cap of 17.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while CXZ.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas CXZ.AX's P/E ratio is 6.29. In terms of profitability, MRI.AX's ROE is +0.47%, compared to CXZ.AX's ROE of +0.24%. Regarding short-term risk, MRI.AX and CXZ.AX have similar daily volatility (0.00).Check CXZ.AX's competition here
MRI.AX vs LNU.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, LNU.AX has a market cap of 16.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while LNU.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas LNU.AX's P/E ratio is -0.20. In terms of profitability, MRI.AX's ROE is +0.47%, compared to LNU.AX's ROE of +3.01%. Regarding short-term risk, MRI.AX and LNU.AX have similar daily volatility (0.00).Check LNU.AX's competition here
MRI.AX vs XF1.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, XF1.AX has a market cap of 15.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while XF1.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas XF1.AX's P/E ratio is -6.67. In terms of profitability, MRI.AX's ROE is +0.47%, compared to XF1.AX's ROE of +0.46%. Regarding short-term risk, MRI.AX is less volatile compared to XF1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check XF1.AX's competition here
MRI.AX vs 1CG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, 1CG.AX has a market cap of 14.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while 1CG.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas 1CG.AX's P/E ratio is -4.40. In terms of profitability, MRI.AX's ROE is +0.47%, compared to 1CG.AX's ROE of -0.03%. Regarding short-term risk, MRI.AX and 1CG.AX have similar daily volatility (0.00).Check 1CG.AX's competition here
MRI.AX vs LOC.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, LOC.AX has a market cap of 13.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while LOC.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas LOC.AX's P/E ratio is -5.60. In terms of profitability, MRI.AX's ROE is +0.47%, compared to LOC.AX's ROE of -1.73%. Regarding short-term risk, MRI.AX and LOC.AX have similar daily volatility (0.00).Check LOC.AX's competition here
MRI.AX vs GTI.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, GTI.AX has a market cap of 12.9M. Regarding current trading prices, MRI.AX is priced at A$0.01, while GTI.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas GTI.AX's P/E ratio is -1.18. In terms of profitability, MRI.AX's ROE is +0.47%, compared to GTI.AX's ROE of -1.24%. Regarding short-term risk, MRI.AX is less volatile compared to GTI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check GTI.AX's competition here
MRI.AX vs HTG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, HTG.AX has a market cap of 12.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while HTG.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas HTG.AX's P/E ratio is -1.45. In terms of profitability, MRI.AX's ROE is +0.47%, compared to HTG.AX's ROE of +0.65%. Regarding short-term risk, MRI.AX and HTG.AX have similar daily volatility (0.00).Check HTG.AX's competition here
MRI.AX vs FLX.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, FLX.AX has a market cap of 11.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while FLX.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas FLX.AX's P/E ratio is -2.07. In terms of profitability, MRI.AX's ROE is +0.47%, compared to FLX.AX's ROE of -1.52%. Regarding short-term risk, MRI.AX and FLX.AX have similar daily volatility (0.00).Check FLX.AX's competition here
MRI.AX vs NVQ.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, NVQ.AX has a market cap of 11.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while NVQ.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas NVQ.AX's P/E ratio is -3.90. In terms of profitability, MRI.AX's ROE is +0.47%, compared to NVQ.AX's ROE of +3.27%. Regarding short-term risk, MRI.AX is less volatile compared to NVQ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check NVQ.AX's competition here
MRI.AX vs NOR.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, NOR.AX has a market cap of 10.9M. Regarding current trading prices, MRI.AX is priced at A$0.01, while NOR.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas NOR.AX's P/E ratio is -6.97. In terms of profitability, MRI.AX's ROE is +0.47%, compared to NOR.AX's ROE of +1.09%. Regarding short-term risk, MRI.AX is less volatile compared to NOR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check NOR.AX's competition here
MRI.AX vs AHE.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, AHE.AX has a market cap of 10.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while AHE.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas AHE.AX's P/E ratio is 1.52. In terms of profitability, MRI.AX's ROE is +0.47%, compared to AHE.AX's ROE of -10.86%. Regarding short-term risk, MRI.AX is less volatile compared to AHE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check AHE.AX's competition here
MRI.AX vs RCL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, RCL.AX has a market cap of 10.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while RCL.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas RCL.AX's P/E ratio is 3.43. In terms of profitability, MRI.AX's ROE is +0.47%, compared to RCL.AX's ROE of -0.20%. Regarding short-term risk, MRI.AX is less volatile compared to RCL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check RCL.AX's competition here
MRI.AX vs Z2U.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, Z2U.AX has a market cap of 10.3M. Regarding current trading prices, MRI.AX is priced at A$0.01, while Z2U.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas Z2U.AX's P/E ratio is -5.10. In terms of profitability, MRI.AX's ROE is +0.47%, compared to Z2U.AX's ROE of -1.73%. Regarding short-term risk, MRI.AX is less volatile compared to Z2U.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check Z2U.AX's competition here
MRI.AX vs NOV.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, NOV.AX has a market cap of 10M. Regarding current trading prices, MRI.AX is priced at A$0.01, while NOV.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas NOV.AX's P/E ratio is -10.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to NOV.AX's ROE of -0.78%. Regarding short-term risk, MRI.AX is less volatile compared to NOV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check NOV.AX's competition here
MRI.AX vs 8CO.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, 8CO.AX has a market cap of 9M. Regarding current trading prices, MRI.AX is priced at A$0.01, while 8CO.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas 8CO.AX's P/E ratio is -10.26. In terms of profitability, MRI.AX's ROE is +0.47%, compared to 8CO.AX's ROE of -0.11%. Regarding short-term risk, MRI.AX and 8CO.AX have similar daily volatility (0.00).Check 8CO.AX's competition here
MRI.AX vs CAG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, CAG.AX has a market cap of 8.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while CAG.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas CAG.AX's P/E ratio is -9.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to CAG.AX's ROE of -0.26%. Regarding short-term risk, MRI.AX and CAG.AX have similar daily volatility (0.00).Check CAG.AX's competition here
MRI.AX vs OOK.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, OOK.AX has a market cap of 8.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while OOK.AX trades at A$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas OOK.AX's P/E ratio is -6.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to OOK.AX's ROE of -0.27%. Regarding short-term risk, MRI.AX and OOK.AX have similar daily volatility (0.00).Check OOK.AX's competition here
MRI.AX vs OLL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, OLL.AX has a market cap of 7.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while OLL.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas OLL.AX's P/E ratio is -2.07. In terms of profitability, MRI.AX's ROE is +0.47%, compared to OLL.AX's ROE of +4.98%. Regarding short-term risk, MRI.AX and OLL.AX have similar daily volatility (0.00).Check OLL.AX's competition here
MRI.AX vs KNM.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, KNM.AX has a market cap of 7.2M. Regarding current trading prices, MRI.AX is priced at A$0.01, while KNM.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas KNM.AX's P/E ratio is -5.56. In terms of profitability, MRI.AX's ROE is +0.47%, compared to KNM.AX's ROE of -0.60%. Regarding short-term risk, MRI.AX and KNM.AX have similar daily volatility (0.00).Check KNM.AX's competition here
MRI.AX vs LVT.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, LVT.AX has a market cap of 7.1M. Regarding current trading prices, MRI.AX is priced at A$0.01, while LVT.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas LVT.AX's P/E ratio is -0.10. In terms of profitability, MRI.AX's ROE is +0.47%, compared to LVT.AX's ROE of -0.69%. Regarding short-term risk, MRI.AX is less volatile compared to LVT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check LVT.AX's competition here
MRI.AX vs SIS.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SIS.AX has a market cap of 6.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while SIS.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SIS.AX's P/E ratio is -2.86. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SIS.AX's ROE of +2.27%. Regarding short-term risk, MRI.AX and SIS.AX have similar daily volatility (0.00).Check SIS.AX's competition here
MRI.AX vs SYT.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, SYT.AX has a market cap of 5.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while SYT.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas SYT.AX's P/E ratio is N/A. In terms of profitability, MRI.AX's ROE is +0.47%, compared to SYT.AX's ROE of +0.39%. Regarding short-term risk, MRI.AX and SYT.AX have similar daily volatility (0.00).Check SYT.AX's competition here
MRI.AX vs RLG.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, RLG.AX has a market cap of 5.7M. Regarding current trading prices, MRI.AX is priced at A$0.01, while RLG.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas RLG.AX's P/E ratio is -5.45. In terms of profitability, MRI.AX's ROE is +0.47%, compared to RLG.AX's ROE of -0.80%. Regarding short-term risk, MRI.AX and RLG.AX have similar daily volatility (0.00).Check RLG.AX's competition here
MRI.AX vs PRO.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, PRO.AX has a market cap of 5.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while PRO.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas PRO.AX's P/E ratio is -0.69. In terms of profitability, MRI.AX's ROE is +0.47%, compared to PRO.AX's ROE of +7.84%. Regarding short-term risk, MRI.AX is less volatile compared to PRO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check PRO.AX's competition here
MRI.AX vs CDE.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, CDE.AX has a market cap of 5.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while CDE.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas CDE.AX's P/E ratio is -0.90. In terms of profitability, MRI.AX's ROE is +0.47%, compared to CDE.AX's ROE of -7.61%. Regarding short-term risk, MRI.AX is less volatile compared to CDE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check CDE.AX's competition here
MRI.AX vs TYM.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, TYM.AX has a market cap of 5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while TYM.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas TYM.AX's P/E ratio is 0.40. In terms of profitability, MRI.AX's ROE is +0.47%, compared to TYM.AX's ROE of -1.39%. Regarding short-term risk, MRI.AX and TYM.AX have similar daily volatility (0.00).Check TYM.AX's competition here
MRI.AX vs WOO.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, WOO.AX has a market cap of 4.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while WOO.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas WOO.AX's P/E ratio is -2.00. In terms of profitability, MRI.AX's ROE is +0.47%, compared to WOO.AX's ROE of -0.89%. Regarding short-term risk, MRI.AX is less volatile compared to WOO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check WOO.AX's competition here
MRI.AX vs BGE.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, BGE.AX has a market cap of 4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while BGE.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas BGE.AX's P/E ratio is -3.33. In terms of profitability, MRI.AX's ROE is +0.47%, compared to BGE.AX's ROE of -0.92%. Regarding short-term risk, MRI.AX and BGE.AX have similar daily volatility (0.00).Check BGE.AX's competition here
MRI.AX vs AER.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, AER.AX has a market cap of 4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while AER.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas AER.AX's P/E ratio is -11.18. In terms of profitability, MRI.AX's ROE is +0.47%, compared to AER.AX's ROE of -0.35%. Regarding short-term risk, MRI.AX and AER.AX have similar daily volatility (0.00).Check AER.AX's competition here
MRI.AX vs OPA.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, OPA.AX has a market cap of 3.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while OPA.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas OPA.AX's P/E ratio is -0.30. In terms of profitability, MRI.AX's ROE is +0.47%, compared to OPA.AX's ROE of N/A. Regarding short-term risk, MRI.AX is less volatile compared to OPA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check OPA.AX's competition here
MRI.AX vs ID8.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, ID8.AX has a market cap of 2.8M. Regarding current trading prices, MRI.AX is priced at A$0.01, while ID8.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas ID8.AX's P/E ratio is -0.57. In terms of profitability, MRI.AX's ROE is +0.47%, compared to ID8.AX's ROE of -5.25%. Regarding short-term risk, MRI.AX is less volatile compared to ID8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check ID8.AX's competition here
MRI.AX vs DCL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, DCL.AX has a market cap of 2.6M. Regarding current trading prices, MRI.AX is priced at A$0.01, while DCL.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas DCL.AX's P/E ratio is -0.83. In terms of profitability, MRI.AX's ROE is +0.47%, compared to DCL.AX's ROE of +2.22%. Regarding short-term risk, MRI.AX is less volatile compared to DCL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check DCL.AX's competition here
MRI.AX vs PHL.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, PHL.AX has a market cap of 2.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while PHL.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas PHL.AX's P/E ratio is -0.90. In terms of profitability, MRI.AX's ROE is +0.47%, compared to PHL.AX's ROE of +0.44%. Regarding short-term risk, MRI.AX and PHL.AX have similar daily volatility (0.00).Check PHL.AX's competition here
MRI.AX vs PFM.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, PFM.AX has a market cap of 2.5M. Regarding current trading prices, MRI.AX is priced at A$0.01, while PFM.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas PFM.AX's P/E ratio is -6.44. In terms of profitability, MRI.AX's ROE is +0.47%, compared to PFM.AX's ROE of -0.43%. Regarding short-term risk, MRI.AX is less volatile compared to PFM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MRI.AX.Check PFM.AX's competition here
MRI.AX vs AO1.AX Comparison July 2026
MRI.AX plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRI.AX stands at 8.2M. In comparison, AO1.AX has a market cap of 2.4M. Regarding current trading prices, MRI.AX is priced at A$0.01, while AO1.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRI.AX currently has a P/E ratio of -2.52, whereas AO1.AX's P/E ratio is -3.45. In terms of profitability, MRI.AX's ROE is +0.47%, compared to AO1.AX's ROE of -0.15%. Regarding short-term risk, MRI.AX and AO1.AX have similar daily volatility (0.00).Check AO1.AX's competition here